EUVIMEDEUVIMED entdecken
Crossref

A Single Institution Retrospective Review of Pancreatic Stereotactic Body Radiotherapy Outcomes

Aaron Jin, Nam Nguyen iD, Adrian Esterman, Vinh-An Phan, Nimit Singhal, Laurence Kim, Rahul Mukherjee, Hien Le

Journal of Medical Imaging and Radiation Oncology · 24.06.2026

DOI: 10.1111/1754-9485.70141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Imaging and Radiation Oncology, online erschienen am 24.06.2026. Verfasst von Aaron Jin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia. Die Arbeit nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pancreatic cancer carries a disproportionate burden of mortality and highlights a need to identify therapies that improve local control and survival outcomes. Radiotherapy is an option for the large proportion of patients who are surgically unresectable but has previously been restricted by surrounding dose‐limiting organs. The use of stereotactic body radiotherapy (SBRT) can overcome these limitations and deliver a higher biologically equivalent dose to improve local control.

Methods

Eighty‐seven patients with locally advanced, unresectable and histologically confirmed pancreatic adenocarcinoma treated with SBRT were enrolled. Patients underwent SBRT with endoscopic fiducial seed guidance, with either concurrent chemotherapy or dose‐escalated radiotherapy alone. Fractionation regimens ranged from 3 to 5 fractions.

Results

With a median follow up of 8 months (range 8–51), the median overall survival was 8 months. The local control in those alive at 1 year was 75%. Five patients had Grade 3 toxicity and 5 had moderate (Grade 2) toxicity, with the remaining patients having mild or no toxicity. There were no Grade 4 or greater toxicities.

Conclusion

SBRT potentially bypasses the dose limitations of adjacent organs compared with conventional radiotherapy, allowing for improved local control and shorter treatment times. The additional benefit of manageable toxicities makes this an appealing therapy for patients with unresectable pancreatic cancer.

Schlagwörter

Stichwörter der Autor:innen

SBRTlocally advancedpancreatic cancerstereotactic body radiotherapyunresectable

Autor:innen und Institutionen

  • Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Department of Gastroenterology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Allied Health and Human Performance, University of South Australia, Adelaide, South Australia, Australia.
  • Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Radiation Oncology, GenesisCare, Adelaide, South Australia, Australia.

ORCID-Profile: Nam Nguyen

Zitieren

APA

Jin, A., Nguyen, N., Esterman, A., Phan, V. A., Singhal, N., Kim, L., Mukherjee, R., & Le, H. (2026). A Single Institution Retrospective Review of Pancreatic Stereotactic Body Radiotherapy Outcomes. Journal of Medical Imaging and Radiation Oncology. https://doi.org/10.1111/1754-9485.70141

Vancouver

Jin A, Nguyen N, Esterman A, Phan VA, Singhal N, Kim L, et al. A Single Institution Retrospective Review of Pancreatic Stereotactic Body Radiotherapy Outcomes. Journal of Medical Imaging and Radiation Oncology. 2026. doi:10.1111/1754-9485.70141

BibTeX
@article{Jin2026,
  author = {Jin, Aaron and Nguyen, Nam and Esterman, Adrian and Phan, Vinh-An and Singhal, Nimit and Kim, Laurence and Mukherjee, Rahul and Le, Hien},
  title = {A Single Institution Retrospective Review of Pancreatic Stereotactic Body Radiotherapy Outcomes},
  journal = {Journal of Medical Imaging and Radiation Oncology},
  year = {2026},
  doi = {10.1111/1754-9485.70141}
}
Kostenlos starten →